AI English summary of an SEC filing — figures as filed
TransDigm Group said it recorded net sales of $2,150 million, net income attributable to TD Group of $479 million and EBITDA As Defined of $1,162 million, or 54.0% of net sales, for Q2 of fiscal 2025.
Key points
AI summaryTransDigm Group said it recorded net sales of $2,150 million, net income attributable to TD Group of $479 million and EBITDA As Defined of $1,162 million, or 54.0% of net sales, for Q2 of fiscal 2025.
The company said organic sales for the 13 weeks ended March 29, 2025 increased $132 million, with commercial aftermarket up $77 million, or 13.3%, defense up $69 million, or 9.5%, and commercial OEM down $1 million, or 0.2%.
TransDigm Group said cost of sales for the 13 weeks increased to $876 million, or 14.2%, and rose as a percentage of net sales, citing foreign currency losses recognized as the U.S. dollar weakened against the British pound and the euro. Excluding the impact of foreign currency gains and losses, the ratio declined slightly, it added.
The company said it paid a special cash dividend of $75.00 per share on October 18, 2024, including $4,216 million and dividend equivalents of $131 million, and repurchased shares for $316 million in Q1 of fiscal 2025 and $53 million in Q2.
Key figures
Quarter ended March 29, 2025
- Revenue
- $2.1B
- Operating income
- $991M
- Net income
- $479M
- EPS
- $8.24
- Gross profit
- $1.3B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q2 Net Sales, Net Income and EBITDA As Defined
TransDigm Group said it recorded net sales of $2,150 million, net income attributable to TD Group of $479 million and EBITDA As Defined of $1,162 million, or 54.0% of net sales, for Q2 of fiscal 2025.
Source · Based on the MD&A text of the filing
13-Week Organic Sales Growth Composition
The company said organic sales for the 13 weeks ended March 29, 2025 increased $132 million, with commercial aftermarket up $77 million, or 13.3%, defense up $69 million, or 9.5%, and commercial OEM down $1 million, or 0.2%.
Source · Based on the MD&A text of the filing
13-Week Cost of Sales Ratio and Foreign Currency Impact
TransDigm Group said cost of sales for the 13 weeks increased to $876 million, or 14.2%, and rose as a percentage of net sales, citing foreign currency losses recognized as the U.S. dollar weakened against the British pound and the euro. Excluding the impact of foreign currency gains and losses, the ratio declined slightly, it added.
Source · Based on the MD&A text of the filing
Special Cash Dividend and Share Repurchases
The company said it paid a special cash dividend of $75.00 per share on October 18, 2024, including $4,216 million and dividend equivalents of $131 million, and repurchased shares for $316 million in Q1 of fiscal 2025 and $53 million in Q2.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…